66 related articles for article (PubMed ID: 27330792)
1. Hepatitis B virus reactivation in hepatocellular carcinoma patients after hepatic arterial infusion chemotherapy combined with and without immunotherapy.
Zhang L; Liu Y; Song S; Makamure J; Shi H; Zheng C; Liang B
Infect Agent Cancer; 2024 Apr; 19(1):19. PubMed ID: 38693564
[TBL] [Abstract][Full Text] [Related]
2. Inverse relationship between HBV DNA levels and liver histopathological changes in immune-tolerant CHB patients.
Huang D; Lai H; Zhu Z; Yu H; Peng J; Chen Y; Liao X; Chen J
J Viral Hepat; 2024 Jul; 31(7):363-371. PubMed ID: 38581159
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus antigens impair NK cell function.
Yang Y; Han Q; Zhang C; Xiao M; Zhang J
Int Immunopharmacol; 2016 Sep; 38():291-7. PubMed ID: 27341035
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of chronic hepatitis B: 2009 update.
Morgan M; Keeffe EB
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):5-22. PubMed ID: 19212304
[TBL] [Abstract][Full Text] [Related]
5. Analysis of baseline hepatitis B virus DNA levels in chronic hepatitis B patients with non-hematological malignancies prior to the initiation of cancer chemotherapy.
Young SH; Wei TH; Lin CC; Chu CJ; Lee FY; Yu MI; Lu RH; Chang CY; Yang PL; Wang MH; Lin HC
Mol Clin Oncol; 2016 Jul; 5(1):165-170. PubMed ID: 27330792
[TBL] [Abstract][Full Text] [Related]
6. Baseline HBsAg levels associated with HBsAg loss in HBeAg-negative chronic hepatitis B infection with persistently normal alanine aminotransferase.
Chen L; Shi J; Lu Z; Ye Y; Zhou X; Tan Y
Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):310-316. PubMed ID: 30528063
[TBL] [Abstract][Full Text] [Related]
7. Role of hepatitis B surface antigen in hepatitis B virus relapse after entecavir or tenofovir prophylaxis in patients undergoing cancer chemotherapy.
Kuo MT; Tseng PL; Chou YP; Chang KC; Tsai MC; Kuo YH; Hu TH; Hung CH; Wang JH; Lu SN; Chen CH
J Gastroenterol Hepatol; 2018 Oct; 33(10):1766-1772. PubMed ID: 29514418
[TBL] [Abstract][Full Text] [Related]
8. Risk of Severe Acute Exacerbation of Chronic HBV Infection Cancer Patients Who Underwent Chemotherapy and Did Not Receive Anti-Viral Prophylaxis.
Shih CA; Chen WC; Yu HC; Cheng JS; Lai KH; Hsu JT; Chen HC; Hsu PI
PLoS One; 2015; 10(8):e0132426. PubMed ID: 26274393
[TBL] [Abstract][Full Text] [Related]
9. Prediction of disease reactivation in asymptomatic hepatitis B e antigen-negative chronic hepatitis B patients using baseline serum measurements of HBsAg and HBV-DNA.
Martinot-Peignoux M; Lapalus M; Laouénan C; Lada O; Netto-Cardoso AC; Boyer N; Ripault MP; Carvalho-Filho R; Asselah T; Marcellin P
J Clin Virol; 2013 Oct; 58(2):401-7. PubMed ID: 24004660
[TBL] [Abstract][Full Text] [Related]
10. Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy.
Law MF; Ho R; Cheung CK; Tam LH; Ma K; So KC; Ip B; So J; Lai J; Ng J; Tam TH
World J Gastroenterol; 2016 Jul; 22(28):6484-500. PubMed ID: 27605883
[TBL] [Abstract][Full Text] [Related]
11. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update.
Liaw YF; Kao JH; Piratvisuth T; Chan HL; Chien RN; Liu CJ; Gane E; Locarnini S; Lim SG; Han KH; Amarapurkar D; Cooksley G; Jafri W; Mohamed R; Hou JL; Chuang WL; Lesmana LA; Sollano JD; Suh DJ; Omata M
Hepatol Int; 2012 Jun; 6(3):531-61. PubMed ID: 26201469
[TBL] [Abstract][Full Text] [Related]
12. Management of patients with hepatitis B who require immunosuppressive therapy.
Hwang JP; Lok AS
Nat Rev Gastroenterol Hepatol; 2014 Apr; 11(4):209-19. PubMed ID: 24247262
[TBL] [Abstract][Full Text] [Related]
13. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study.
Marcellin P; Gane E; Buti M; Afdhal N; Sievert W; Jacobson IM; Washington MK; Germanidis G; Flaherty JF; Aguilar Schall R; Bornstein JD; Kitrinos KM; Subramanian GM; McHutchison JG; Heathcote EJ
Lancet; 2013 Feb; 381(9865):468-75. PubMed ID: 23234725
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus reactivation associated with anti-neoplastic therapy.
Yeo W; Chan HL
J Gastroenterol Hepatol; 2013 Jan; 28(1):31-7. PubMed ID: 23020594
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
